Covid-19 (Temas de Saúde Pública)

Estudo randomizado | Vacinação heteróloga de AD5-nCOV com CoronaVac vs. vacinação homóloga com CoronaVac.

28 Jan, 2022 | 17:20h

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial – Nature Medicine

Conteúdos relacionados:

RCT: Heterologous (Pfizer, J&J, or AstraZeneca) vs. homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil.

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination – Nature Medicine

WHO issues interim recommendations for heterologous COVID-19 vaccine schedules.

---

Após a Ômicron, alguns cientistas preveem “um período de calmaria”.

28 Jan, 2022 | 17:19h

After Omicron, some scientists foresee ‘a period of quiet’ – Science

---

Perspectiva | A variante Ômicron tornará imune a maioria de nós?

28 Jan, 2022 | 17:18h

Will Omicron Leave Most of Us Immune? – The Atlantic

---

Uma segunda versão da variante Ômicron está se disseminando. Este é o motivo de os cientistas estarem alertas.

28 Jan, 2022 | 17:16h

A second version of omicron is spreading. Here’s why scientists are on alert – NPR

Ver também: Scientists Watch, Worry About New ‘Stealth’ Version of Omicron Variant – HealthDay

---

Eles construíram uma abordagem mais inteligente para os estudos clínicos de Covid. Agora, eles querem fazer o mesmo para outras doenças.

28 Jan, 2022 | 17:15h

They built a smarter approach to Covid clinical trials. Now they want to do the same for other diseases – STAT

---

O lado positivo da moeda: a pandemia de SARS-CoV-2 nos ensinou sobre o quanto a telemedicina é útil como procedimento padrão de cuidado na vida real.

28 Jan, 2022 | 17:14h

The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life – Clinical Rheumatology

---

Casualidades da COVID: insulina e diálise – “Como a pandemia tem sido uma ameaça à vida de pessoas com diabetes e doença renal crônica.”

28 Jan, 2022 | 17:13h

Casualties of COVID: Insulin and Dialysis - Think Global Health

---

Estudo laboratorial mostra que novas pílulas antivirais mantêm sua eficácia contra a variante Ômicron, mas anticorpos monoclonais são substancialmente menos efetivos.

28 Jan, 2022 | 16:28h

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant – New England Journal of Medicine

Comentário: Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study finds – University of Wisconsin-Madison

 

Comentário no Twitter

Investigators assessed the in vitro activities of seven monoclonal antibodies & three antiviral drugs against #COVID19 variants. All antibodies showed no or weak neutralizing activity against omicron; two drugs effective at omicron neutralization. https://t.co/rOZzmtsDZS pic.twitter.com/shfKDW6r5q

— NEJM (@NEJM) January 26, 2022

 

---

Opinião | Apesar da chegada da variante Ômicron, o objetivo deveria ser manter as escolas abertas do modo mais seguro possível.

28 Jan, 2022 | 16:24h

Despite Omicron arriving, keeping schools open as safely as possible should be the goal – The Conversation

---

Alerta crucial da variante Ômicron: uma doença pode mudar mais rápido do que nós.

28 Jan, 2022 | 16:23h

Omicron’s most crucial warning: A disease can move much faster than we can – Vox

---